Evaluation of a Hysteroscopic Morcellator in Hysteroscopic Treatment of Submucosal Fibroids

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2018-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hysteroscopic surgery is the gold standard for intra uterine pathology especially fibroma. Limit of this technic is duration of procedure which is correlated to operative complications. So, for patient with large fibrome or several fibromas, this technic is not indicated or performs in several times. A new technic of hysteroscopic surgery is available which is quicker than conventional technic. This technic is poorly evaluated. Aim of this study is to evaluate both technics on procedure duration.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fibroids

NCT05078307

Uterine Fibroids

UNKNOWN NA

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

NCT06882824

Myoma;Uterus Myomectomy; Surgical Blood Loss

RECRUITING NA

Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy

NCT02472197

Endometrial Polyps

COMPLETED NA

The Hysteroscopic Morcellator (HM).

NCT01537822

Large Intrauterine Polyps Smaller Type 0 and 1 Myomas Residual Placental Tissue

COMPLETED NA

Laparoscopic Myomectomy With Morcellation or Transvaginal Extraction of Surgical Specimens.

NCT03570879

Myoma;Uterus

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Material and Methods

We propose a monocentric-randomised study. Inclusion criteria are women over 18 years requiring hysteroscopic surgery for fibroma. After informed consent, patients will be randomised in two groups: hysteroscopic surgery with morcellation technic and conventional hysteroscopy technic with resection. The main objective is duration of procedure. Secondary objectives are characteristics and perioperative complications (distension media quantity, cervical injury, uterine perforation), immediate et long term postoperative data's (postoperative pain and synechia). We hypothesis hysteroscopic with morcellation reduces duration of procedure of 50%. The estimated size of population number is 30 per group and 60 for the study.

Expected results

We expected a significant decrease of procedure duration with hysteroscopic morcellation. This data will be interesting according peroperative complications are correlated to procedure duration and allow hysteroscopic surgery to patients with large or several fibromas.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Evaluate Both Technics on Procedure Duration Characteristics and Perioperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hysteroscopic surgery with morcellation technic

The hysteroscope with the MH system will be introduced. Resection of fibroids or both will be realized. The procedure will end or when the fibroids will be completely resected.

the procedure may be suspended before complete resection of fibroids or uterine perforation or higher operating time to 90 minutes or amount of liquid used distension than 9 liters or distension fluid deficit of more than one liter .

Group Type EXPERIMENTAL

morcellator uterine system (MH)Karl Storz, Tuttligen- Germany

Intervention Type DEVICE

conventional hysteroscopy technic with resection.

The hysteroscope with conventional resection system will be introduced. Resection of fibroids or both will be realized. The procedure will end or when the fibroids will be completely resected.

the procedure may be suspended before complete resection of fibroids or uterine perforation or higher operating time to 90 minutes or amount of liquid used distension than 9 liters or distension fluid deficit of more than one liter (4 ).

Group Type ACTIVE_COMPARATOR

morcellator uterine system (MH)Karl Storz, Tuttligen- Germany

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

morcellator uterine system (MH)Karl Storz, Tuttligen- Germany

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient under effective contraception.
* Patient who underwent ultrasound confirming the presence of at least one or both uterine fibroids with a diameter less than 6 cm for the largest fibroid.
* Patient who underwent diagnostic hysteroscopy confirming the presence of one or two uterine fibroids classified as Type 0, 1 or 2 according to FIGO classification (10).
* Patient with an indication of intrauterine fibroid resection (bleeding disorders fetilité) by hysteroscopy.
* Patient who agreed to participate in the study and who signed informed consent.